Literature DB >> 32118775

Risk of acute respiratory failure among hospitalized patients with various admission serum albumin levels: A cohort study.

Charat Thongprayoon1, Wisit Cheungpasitporn2, Api Chewcharat1, Michael A Mao3, Sorkko Thirunavukkarasu1, Kianoush B Kashani1,4.   

Abstract

Serum albumin is a marker of nutritional and frailty status. This study aimed to assess the association between serum albumin at the time of admission and the risk of acute respiratory failure (ARF) in hospitalized patientsThis cohort study, performed at a tertiary referral hospital, included all hospitalized adult patients from January 2009 to December 2013 who had serum albumin measurement and were not on mechanical ventilation within 24 hours of hospital admission. Serum albumin was stratified into 2.4, 2.5 to 2.9, 3.0 to 3.4, 3.5 to 3.9, 4.0 to 4.4, and ≥4.5 g/dL. Multivariate logistic regression analysis was performed to obtain adjusted odds ratio (OR) of risk of ARF requiring mechanical ventilation based on various admission serum albumin levels.Of 12,719 patients, ARF requiring mechanical ventilation occurred in 1128 (8.9%) during hospitalization. Hypoalbuminemia was associated with increased risk of ARF, in particular when serum albumin was ≤2.4 g/dL. Compared with serum albumin of 4.0-4.4 g/dL, serum albumin ≤2.4 g/dL at admission was associated with 2.38-time higher odds of ARF during hospitalization (OR 2.38, 95% confidence interval [CI] 1.84-3.07). In contrast, elevated serum albumin ≥4.5 g/dL was associated with lower odds of ARF (OR 0.68, 95% CI 0.48-0.97).Admission serum albumin level lower than 3.5 g/dL was associated with a higher risk of ARF requiring mechanical ventilation, whereas elevated serum albumin level at least 4.5 g/dL was associated with a lower risk of ARF. Therefore, admission albumin level at admission might be useful in the prediction of ARF during hospitalization.

Entities:  

Year:  2020        PMID: 32118775     DOI: 10.1097/MD.0000000000019352

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  6 in total

1.  Is prognostic nutritional index a predictive marker for estimating all-cause in-hospital mortality in COVID-19 patients with cardiovascular risk factors?

Authors:  Tufan Çınar; Mert İlker Hayıroğlu; Vedat Çiçek; Şahhan Kılıç; Süha Asal; Samet Yavuz; Murat Selçuk; Emre Yalçınkaya; Nurgül Keser; Ahmet Lütfullah Orhan
Journal:  Heart Lung       Date:  2021-01-13       Impact factor: 2.210

2.  Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study.

Authors:  María C Viana-Llamas; Ramón Arroyo-Espliguero; J Alberto Silva-Obregón; Giovanna Uribe-Heredia; Iván Núñez-Gil; Belén García-Magallón; Claudio G Torán-Martínez; Alicia Castillo-Sandoval; Eva Díaz-Caraballo; Itsaso Rodríguez-Guinea; Jesús Domínguez-López
Journal:  Med Clin (Engl Ed)       Date:  2021-05-01

3.  Association between postoperative hypoalbuminemia and postoperative pulmonary imaging abnormalities patients undergoing craniotomy for brain tumors: a retrospective cohort study.

Authors:  Da-Wei Zhao; Feng-Chun Zhao; Xu-Yang Zhang; Kai-Yan Wei; Yi-Bin Jiang; Dan Liu; Shui-Xian Zhang; Hua Feng; Rong Hu
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

4.  Risk Factors and Clinical Characteristics of Neonatal Acute Respiratory Distress Syndrome Caused by Early Onset Sepsis.

Authors:  Ting You; Yan-Rong Zhou; Xiao-Chen Liu; Lu-Quan Li
Journal:  Front Pediatr       Date:  2022-03-28       Impact factor: 3.418

5.  Post-chemotherapy pneumonia in Chinese patients with diffuse large B-cell lymphoma: Outcomes and predictive model.

Authors:  Jinrong Zhao; Yan Zhang; Wei Wang; Wei Zhang; Daobin Zhou
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

6.  Serum ionised calcium and the risk of acute respiratory failure in hospitalised patients: a single-centre cohort study in the USA.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Api Chewcharat; Michael A Mao; Kianoush B Kashani
Journal:  BMJ Open       Date:  2020-03-23       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.